Strides Pharma Science has informed that it enclosed the Un-audited Financial Results (Standalone and Consolidated) of the Company along with Limited Review Report of the Statutory Auditors for the quarter ended June 30, 2023, as approved by the Board of Directors of the Company at their meeting held today, August 2, 2023. The Board Meeting commenced at 10:30 hrs IST and concluded at 11:45 hrs IST.
The above information is a part of company’s filings submitted to BSE.